Management of joint replacement surgery with a von Willebrand factor product with a low FVIII content in von Willebrand disease patients

被引：0
|
作者：
Borel-Derlon, A. [1 ]
Federici, A. B. [2 ]
Goudemand, J. [3 ]
Roussel-Robert, V [4 ]
Chatelanaz, C. [6 ]
Henriet, C. [6 ]
Bridey, F. [6 ]
机构：
[1] Univ Hosp, Haemophilia Treatment Ctr, Caen, France
[2] Univ Milan, Bianchi Bonomi Haemophilia & Thrombosis Ctr, I-20122 Milan, Italy
[3] Univ Hosp Lille, Haemophilia Treatment Ctr, Lille, France
[4] Univ Hosp Paris Cochin, Haemophilia Treatment Ctr, Paris, France
[5] Haemophilia Treatment Ctr, Montpellier, France
[6] LFB, Les Ulis, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-WE-469
引用
收藏
页码：668 / 668
页数：1
相关论文
共 50 条
  • [21] Von Willebrand factor binding to heparin in von Willebrand disease
    Rastegar-Lari, G
    Legendre, P
    Ajzenberg, N
    Meyer, D
    Baruch, D
    THROMBOSIS AND HAEMOSTASIS, 1999, : 510 - 511
  • [22] Von Willebrand Factor and von Willebrand disease: prerequisite for diagnostic
    Fressinaud, Edith
    HEMATOLOGIE, 2014, 20 : 6 - 13
  • [23] von Willebrand disease and quantitative variation in von Willebrand factor
    Mohlke, KL
    Ginsburg, D
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1997, 130 (03): : 252 - 261
  • [24] Dose linearity of von Willebrand factor factor VIII concentrate in elective surgery in von Willebrand disease patients.
    Mannucci, PM
    Kyrle, PA
    Schulman, S
    Haertel, S
    Lethagen, S
    BLOOD, 2003, 102 (11) : 312A - 312A
  • [25] Von Willebrand factor (Vonvendi®): the first recombinant product licensed for the treatment of von Willebrand disease
    Franchini, Massimo
    Mannucci, Pier Mannuccio
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (09) : 825 - 830
  • [26] RECOMBINANT VON WILLEBRAND FACTOR: A FIRST-OF-ITS-KIND PRODUCT FOR VON WILLEBRAND DISEASE
    Singal, M.
    Kouides, P. A.
    DRUGS OF TODAY, 2016, 52 (12) : 653 - 664
  • [27] Current management of von Willebrand disease and von Willebrand syndrome
    Stone, Marc E.
    Mazzeffi, Michael
    Derham, Jeffrey
    Korshin, Andre
    CURRENT OPINION IN ANESTHESIOLOGY, 2014, 27 (03) : 353 - 358
  • [28] The management of patients with congenital von Willebrand disease during surgery or other invasive procedures: focus on antihemophilic factor/von Willebrand factor complex
    Franchini, Massimo
    Lippi, Giuseppe
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (03): : 285 - 289
  • [29] Repetitive infusion of purified von Willebrand factor (vWF) in von Willebrand disease (vWd) results in stable increase of factor FVIII (FVIII) and hemostasis.
    Menache, D
    Aronson, DL
    Montgomery, RR
    Kennedy, ND
    Darr, F
    BLOOD, 1998, 92 (10) : 49A - 49A
  • [30] Treatment of Von Willebrand Disease Women Undergoing Childbirth with a Von Willebrand Factor Product with a Low Content of Factor VIII: Results From 4 Multicenter Studies
    Boyer-Neumann, Catherine
    Borel-Derlon, Annie
    Goudemand, Jenny
    Claeyssens, Segolene
    Sie, Pierre-Marie
    Moreau, Philippe
    Bertrand, Marie-Anne
    Rothschild, Chantal
    Guillet, Benoit
    Borg, Jeanne Yvonne
    Chatelanaz, Catherine
    Stevens, Wil
    Bridey, Franoise
    Henriet, Celine
    BLOOD, 2012, 120 (21)
12345